Archive 2013 2013 - 20 Dec 2013 – Destiny Pharma to attend 32nd Annual J.P. Morgan Healthcare Conference, San Francisco - 18 Nov 2013 – 6th European Antibiotic Awareness Day - 07 Nov 2013 – Destiny Pharma to attend BioInfect 2013 Conference - 24 Sep 2013 – Report by CDC details today’s drug-resistant health threats - 19 Sep 2013 – UK Government publish strategy to combat antimicrobial resistance between 2013 and 2018 - 20 May 2013 – Press Release: Part 2 of NIAID-funded US clinical trial of anti-staphylococcal nasal gel XF-73 begins enrollment - 01 Mar 2013 – Chief Medical Officer Dame Sally Davies publishes annual report providing a comprehensive overview of the threat of antimicrobial resistance and infectious diseases - 01 Feb 2013 – New US Therapeutic Guidelines on Antimicrobial Prophylaxis published which recommend that all higher risk surgeries should now decolonise all patients with documented colonisation with S. aureus and not just MRSA - 01 Jan 2013 – US ICU infection rate cut by 44% by Universal bacterial Decolonisation – Hospital Corporation of America (HCA) ICU’s to adopt this regimen during early 2013 - 01 Jan 2013 – Chief Medical Officer Dame Sally Davies says that antibiotic-resistant diseases pose “Apocalyptic” threat and tells MPs that the issue should be added to the UK Government’s national risk register of civil emergencies Archive 2019 2018 2017 2016 2015 2014 2013 2012 2011
